Increasing Systemic Exposure of Methotrexate by Active Efflux Mediated by Multidrug Resistance-Associated Protein 3 (Mrp3/Abcc3)

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2008-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/jpet.108.140475PMID 18719291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prospective qualitative and quantitative non-invasive evaluation of intestinal acute GVHD by contrast-enhanced ultrasound sonography

  2013cited by this paper
• Involvement of Multiple Efflux Transporters in Hepatic Disposition of Fexofenadine

  2008cited by this paper
• Impaired Clearance of Methotrexate in Organic Anion Transporter 3 (Slc22a8) Knockout Mice: A Gender Specific Impact of Reduced Folates

  2008cited by this paper
• Involvement of MRP4 (ABCC4) in the Luminal Efflux of Ceftizoxime and Cefazolin in the Kidney

  2007cited by this paper
• Functional Characterization of Human Proton-Coupled Folate Transporter/Heme Carrier Protein 1 Heterologously Expressed in Mammalian Cells as a Folate Transporter

  2007cited by this paper
• Multidrug resistance-associated proteins 3, 4, and 5

  2007cited by this paper
• Regional Expression and Activity of Breast Cancer Resistance Protein (Bcrp/Abcg2) in Mouse Intestine: Overlapping Distribution with Sulfotransferases

  2007cited by this paper
• Species Difference in the Inhibitory Effect of Nonsteroidal Anti-Inflammatory Drugs on the Uptake of Methotrexate by Human Kidney Slices

  2007cited by this paper
• Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis

  2006cited by this paper
• Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice

  2006cited by this paper
• High‐dose methotrexate in pediatric acute lymphoblastic leukemia: Impact of ABCC2 polymorphisms on plasma concentrations

  2006cited by this paper
• Evaluation of the Role of Multidrug Resistance-Associated Protein (Mrp) 3 and Mrp4 in Hepatic Basolateral Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Abcc3–/– and Abcc4–/– Mice

  2006cited by this paper
• Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides.

  2006influential reference
• Analysis of the In Vivo Functions of Mrp3

  2005cited by this paper
• Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene

  2005cited by this paper
• Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception.

  2005influential reference
• Mechanism of the Pharmacokinetic Interaction between Methotrexate and Benzimidazoles

  2004influential reference
• Mrp4 Confers Resistance to Topotecan and Protects the Brain from Chemotherapy

  2004cited by this paper
• Increased hepatic and renal expressions of multidrug resistance‐associated protein 3 in Eisai hyperbilirubinuria rats

  2004cited by this paper
• ATP-dependent transport of organic anions into isolated basolateral membrane vesicles from rat intestine.

  2004cited by this paper
• Quantitative Evaluation of the Drug-Drug Interactions between Methotrexate and Nonsteroidal Anti-Inflammatory Drugs in the Renal Uptake Process Based on the Contribution of Organic Anion Transporters and Reduced Folate Carrier

  2004cited by this paper
• Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane

  2003cited by this paper
• Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.

  2003cited by this paper
• The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP.

  2002cited by this paper
• Tissue Distribution and Induction of Human Multidrug Resistant Protein 3

  2002cited by this paper
• Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine.

  2002cited by this paper
• LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

  2001cited by this paper
• Inhibition of biliary excretion of methotrexate by probenecid in rats: quantitative prediction of interaction from in vitro data.

  2001influential reference
• Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport.

  2001cited by this paper
• Transport of Drugs Across the Hepatic Sinusoidal Membrane: Sinusoidal Drug Influx and Efflux in the Liver

  2000cited by this paper
• LST-2, a human liver-specific organic anion transporter determine smethotrexate sensitivity in the gastrointestinal cancers

  2000cited by this paper
• Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3)*

  1999cited by this paper
• Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.

  1999influential reference
• Systemic and intestinal pharmacokinetics of methotrexate in patients with inflammatory bowel disease

  1999cited by this paper
• Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats.

  1998cited by this paper
• Physiological Parameter Values for Physiologically Based Pharmacokinetic Models

  1997influential reference
• Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats.

  1997cited by this paper
• Intestinal folate transport: identification of a cDNA involved in folate transport and the functional expression and distribution of its mRNA.

  1996cited by this paper
• Receptor-mediated clearance of G-CSF derivative nartograstim in bone marrow of rats.

  1995cited by this paper
• Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis.

  1994influential reference
• Physiological Parameters in Laboratory Animals and Humans

  1993influential reference
• Clinical Pharmacokinetics of Methotrexate

  1978cited by this paper

• Characterization of intestinal transporters in human ileal spheroid-derived differentiated cells for the prediction of intestinal drug absorption.

  2025cites this paper
• Regulation of folate transport at the mouse arachnoid barrier

  2024cites this paper
• The use of carboxyfluorescein reveals the transport function of MCT6/SLC16A5 associated with CD147 as a chloride-sensitive organic anion transporter in mammalian cells.

  2023cites this paper
• Drug Transporters: Efflux

  2021cites this paper
• The implications of ABCC3 in cancer drug resistance: can we use it as a therapeutic target?

  2021cites this paper
• Comparison of Various Cell Lines and Three-Dimensional Mucociliary Tissue Model Systems to Estimate Drug Permeability Using an In Vitro Transport Study to Predict Nasal Drug Absorption in Rats

  2020cites this paper
• Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV.

  2020cites this paper
• The Circadian Clock Gene Bmal1 Controls Intestinal Exporter MRP2 and Drug Disposition

  2019cites this paper
• Modulation of Hepatic MRP3/ABCC3 by Xenobiotics and Pathophysiological Conditions: Role in Drug Pharmacokinetics.

  2019cites this paper
• ABC Family Transporters.

  2019cites this paper
• Mrp3 Transports Clopidogrel Acyl Glucuronide from the Hepatocytes into Blood

  2018cites this paper
• Enantioselective Drug Recognition by Drug Transporters

  2018cites this paper
• High Expression of UGT1A1/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human.

  2018cites this paper
• Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases

  2017cites this paper
• Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP

  2017cites this paper
• A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.

  2016cites this paper
• Enhanced Platelet Response to Clopidogrel in Abcc3-deficient Mice Due to Its Increased Bioactivation

  2016cites this paper
• Protective mechanisms of resveratrol against methotrexate‐induced renal damage may involve BCRP/ABCG2

  2016cites this paper
• New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition

  2015cites this paper
• Quantitative targeted absolute proteomics for 28 human transporters in plasma membrane of Caco-2 cell monolayer cultured for 2, 3, and 4 weeks.

  2015cites this paper
• The molecular mechanism underlying the induction of hepatic MRP3 expression and function by omeprazole

  2015cites this paper
• Cognitive impact of cytotoxic agents in mice

  2014cites this paper
• Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy.

  2014cites this paper
• Multi-drug resistance protein (Mrp) 3 may be involved in resveratrol protection against methotrexate-induced testicular damage.

  2014cites this paper
• The intestinal absorption of folates.

  2014cites this paper
• The Effect of ABCG2 and ABCC4 on the Pharmacokinetics of Methotrexate in the Brain

  2014cites this paper
• Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis.

  2014cites this paper
• Efffect of the ABCC3 –211C/T polymorphism on clopidogrel responsiveness in patients with percutaneous coronary intervention

  2013cites this paper
• The proton-coupled folate transporter: physiological and pharmacological roles.

  2013cites this paper
• Genetically modified mouse models for oral drug absorption and disposition.

  2013cites this paper
• Contribution of Abcc4-Mediated Gastric Transport to the Absorption and Efficacy of Dasatinib

  2013cites this paper
• Intestinal drug transporters: an overview.

  2013cites this paper
• Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption.

  2013cites this paper
• Genetic and epigenomic footprints of folate.

  2012cites this paper
• Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR

  2012cites this paper
• Contribution of tumoral and host solute carriers to clinical drug response.

  2012influential citation
• Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics

  2012cites this paper
• Impact of Abcc2 [Multidrug Resistance-Associated Protein (Mrp) 2], Abcc3 (Mrp3), and Abcg2 (Breast Cancer Resistance Protein) on the Oral Pharmacokinetics of Methotrexate and Its Main Metabolite 7-Hydroxymethotrexate

  2011cites this paper
• Dose-Dependent Disposition of Methotrexate in Abcc2 and Abcc3 Gene Knockout Murine Models

  2011cites this paper
• Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia

  2011cites this paper
• The involvement of organic anion transporting polypeptide in the hepatic uptake of telmisartan in rats: PET studies with [¹¹C]telmisartan.

  2011cites this paper
• PharmGKB summary: methotrexate pathway.

  2011cites this paper
• Biological Role, Properties, and Therapeutic Applications of the Reduced Folate Carrier (RFC-SLC19A1) and the Proton-Coupled Folate Transporter (PCFT-SLC46A1)

  2011cites this paper
• Systematic screening of human ABCC3 polymorphisms and their effects on MRP3 expression and function.

  2011cites this paper
• Mechanisms of membrane transport of folates into cells and across epithelia.

  2011cites this paper
• Functional Characterization of Multidrug Resistance-Associated Protein 3 (Mrp3/Abcc3) in the Basolateral Efflux of Glucuronide Conjugates in the Mouse Small Intestine

  2010cites this paper
• Secreted Phosphoprotein 1 Upstream Invasive Network Construction and Analysis of Lung Adenocarcinoma Compared with Human Normal Adjacent Tissues by Integrative Biocomputation

  2010cites this paper
• PCFT/SLC46A1による葉酸の吸収機構( ビタミン・バイオファクターのトランスポーター[II])

  2010cites this paper
• Regulation of Hepatobiliary Transporters during Liver Injury

  2010cites this paper
• Mechanisms for Transport of Methotrexate across Apical and Basolateral Membranes in Human Intestinal Epithelial Caco-2 Cells

  2010cites this paper
• P-glycoprotein, but not multidrug resistance protein 4, plays a role in the systemic clearance of irinotecan and SN-38 in mice.

  2010cites this paper
• Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters

  2010cites this paper
• Stereoselective transport of amethopterin enantiomers by the proton-coupled folate transporter.

  2010cites this paper
• Basolateral Efflux Mediated by Multidrug Resistance-Associated Protein 3 (Mrp3/Abcc3) Facilitates Intestinal Absorption of Folates in Mouse

  2010influential citation
• Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo

  2009cites this paper
• Alteration of methotrexate biliary and renal elimination during extrahepatic and intrahepatic cholestasis in rats.

  2009cites this paper
• Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs

  2009cites this paper
• Prediction of the Hepatic and Renal Clearance of Transporter Substrates in Rats Using in Vitro Uptake Experiments

  2009cites this paper
• Impact of Abcc2 (Mrp2), Abcc3 (Mrp3) and Abcg2 (Bcrp1) on the oral pharmacokinetics of the anti- cancer drug methotrexate and its main metabolite 7- hydroxymethotrexate in mice

  2009influential citation
• ABC transporter compound knockout mice : physiological and pharmacological characterization

  2009cites this paper
• Site-specific contribution of proton-coupled folate transporter/haem carrier protein 1 in the intestinal absorption of methotrexate in rats.

  2009cites this paper
• In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney.

  2009cites this paper
• Microsoft Word-55038909-file00

  2009cites this paper
• Site‐specific contribution of proton‐coupled folate transporter/haem carrier protein 1 in the intestinal absorption of methotrexate in rats

  2009influential citation
• Construction of Triple-Transfected Cells [Organic Anion-Transporting Polypeptide (OATP) 1B1/Multidrug Resistance-Associated Protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for Analysis of the Sinusoidal Function of MRP3 and MRP4

  2009cites this paper